Concepedia

Publication | Closed Access

Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma

DOI

82

Citations

25

References

2010

Year

Hephzibah Rani S. Tagaram, Nicole A. DiVittore, Brian M. Barth, J. Kaiser, Diego M. Avella, Eric T. Kimchi, Yixing Jiang, Harriet C. Isom, Mark Kester, Kevin F. Staveley-O’Carroll
Gut

Abstract

These studies show that nanoliposomal ceramide is an efficacious antineoplastic agent for the treatment of in vitro and in vivo models of human HCC.

References

YearCitations

Page 1